News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | The role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies

News

December 28, 2022
PRESS RELEASE: On December 17, 2022, a new research paper was published in Oncotarget, entitled, “The role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies.” continue reading »

Oncoscience | Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective

News

December 27, 2022
PRESS RELEASE: On December 21, 2022, a new research perspective was published in Oncoscience, entitled, “Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective.” continue reading »

Oncotarget | Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

Oncotarget

December 22, 2022
PRESS RELEASE: A new research paper was published in Oncotarget, entitled, “Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients.” continue reading »

Aging | White matter hyperintensity load is associated with premature brain aging

Aging

December 22, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 23, entitled, “White matter hyperintensity load is associated with premature brain aging.” continue reading »

Aging | DNA methylation GrimAge version 2

Aging

December 21, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 23, entitled, “DNA methylation GrimAge version 2.” continue reading »